India · Delayed Price · Currency is INR SMS Pharmaceuticals Statistics
Total Valuation
BOM:532815 has a market cap or net worth of INR 21.04 billion. The enterprise value is 23.73 billion.
| Market Cap | 21.04B |
| Enterprise Value | 23.73B |
Important Dates
The last earnings date was Wednesday, August 6, 2025.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | Sep 22, 2025 |
Share Statistics
| Current Share Class | 88.65M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.52% |
| Shares Change (QoQ) | +4.79% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 45.35M |
Valuation Ratios
The trailing PE ratio is 28.77.
| PE Ratio | 28.77 |
| Forward PE | n/a |
| PS Ratio | 2.58 |
| PB Ratio | 3.29 |
| P/TBV Ratio | 3.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 32.45 |
| EV / Sales | 2.91 |
| EV / EBITDA | 16.06 |
| EV / EBIT | 21.09 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.49 |
| Debt / EBITDA | 2.15 |
| Debt / FCF | n/a |
| Interest Coverage | 5.54 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.72% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 6.80M |
| Profits Per Employee | 611,084 |
| Employee Count | 1,197 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532815 has paid 251.38 million in taxes.
| Income Tax | 251.38M |
| Effective Tax Rate | 25.58% |
Stock Price Statistics
The stock price has decreased by -22.64% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -22.64% |
| 50-Day Moving Average | 238.45 |
| 200-Day Moving Average | 234.39 |
| Relative Strength Index (RSI) | 56.97 |
| Average Volume (20 Days) | 5,610 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532815 had revenue of INR 8.14 billion and earned 731.47 million in profits. Earnings per share was 8.53.
| Revenue | 8.14B |
| Gross Profit | 2.66B |
| Operating Income | 1.09B |
| Pretax Income | 982.84M |
| Net Income | 731.47M |
| EBITDA | 1.44B |
| EBIT | 1.09B |
| Earnings Per Share (EPS) | 8.53 |
Balance Sheet
The company has 415.86 million in cash and 3.11 billion in debt, giving a net cash position of -2.69 billion.
| Cash & Cash Equivalents | 415.86M |
| Total Debt | 3.11B |
| Net Cash | -2.69B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 6.40B |
| Book Value Per Share | 72.15 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 32.71%, with operating and profit margins of 13.40% and 8.98%.
| Gross Margin | 32.71% |
| Operating Margin | 13.40% |
| Pretax Margin | 12.07% |
| Profit Margin | 8.98% |
| EBITDA Margin | 17.73% |
| EBIT Margin | 13.40% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 0.17%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 0.17% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -1.52% |
| Shareholder Yield | -1.35% |
| Earnings Yield | 3.48% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 17, 2015. It was a forward split with a ratio of 10.
| Last Split Date | Dec 17, 2015 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |